Berman Capital Advisors’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
$21K Buy
75
+37
+97% +$9.49K ﹤0.01% 974
2021
Q2
$7K Buy
38
+10
+36% +$1.94K ﹤0.01% 1250
2021
Q1
$5K Buy
28
+15
+115% +$3.08K ﹤0.01% 1285
2020
Q4
$2K Buy
13
+3
+30% +$546 ﹤0.01% 1430
2020
Q3
$1K Hold
10
﹤0.01% 1502
2020
Q2
$1K Buy
+10
New +$1.18K ﹤0.01% 1490

Other funds holding RGEN

Berman Capital Advisors's RGEN Position: Q3 2021 in Review

Berman Capital Advisors increased its Repligen (RGEN) stake by 97% in Q3 2021, buying an estimated $9.49K and bringing the position to 75 shares worth $21K. The position accounts for ﹤0.01% of the portfolio, ranked #974.

Berman Capital Advisors first reported a position in RGEN in Q2 2020 and has held it in 6 quarters since. 479 funds tracked by Wall St. Rank hold RGEN as of Q3 2021.

  • Berman Capital Advisors held 75 shares of Repligen worth $21K as of Q3 2021.
  • Berman Capital Advisors bought 37 Repligen shares in Q3 2021, an estimated $9.49K.
  • Repligen made up ﹤0.01% of Berman Capital Advisors's portfolio in Q3 2021, its #974 holding.
  • Berman Capital Advisors first reported a position in Repligen in Q2 2020 and has held it in 6 quarters since.
  • 479 funds tracked by Wall St. Rank held Repligen as of Q3 2021.

Based on Berman Capital Advisors's 13F filing for Q3 2021, filed 7 Oct 2021.